T1	Participants 30 61	chronic immune thrombocytopenia
T2	Participants 292 337	patients with chronic immune thrombocytopenia
T3	Participants 437 581	adults with previously treated immune thrombocytopenia of more than 6 months' duration who had baseline platelet counts lower than 30,000 per μL
T4	Participants 829 954	stratified by baseline platelet count (≤ 15,000 per μL), use of treatment for immune thrombocytopenia, and splenectomy status
T5	Participants 1508 1520	197 patients
T6	Participants 2860 2928	patients who have not responded to splenectomy or previous treatment
